Literature DB >> 22783437

Oxaliplatin-induced acute-onset thrombocytopenia and hemorrhage: Case report and review of the literature.

Shoichiro Ohta1, Yukiko Cho, Shinji Oshima, Osamu Hosoya, Kazuhiko Juni, Hiroshi Kojima.   

Abstract

We report the case of a woman who developed acute thrombocytopenia with hemorrhagic diathesis during adjuvant treatment of colorectal adenocarcinoma with oxaliplatin, 5-fluorouracil and leucovorin. A 55-year-old woman started adjuvant chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin (mFOLFOX6). Prior to starting the 12th course of chemotherapy, a complete blood cell count showed the following values: neutrophils 1800/mm(3), platelets 136,000/m(3) and hemoglobin 11.1 g/dl. A blood count revealed that the platelet levels had dropped to 35,000/mm(3), with no significant changes in hemoglobin levels following the course. The administration of corticosteroids was begun and the platelet number was recovered. Clinicians should be aware of the possibility of oxaliplatin-induced hematological emergencies during the treatment of colorectal cancer patients in order to optimize supportive treatment and avoid toxic mortality.

Entities:  

Year:  2012        PMID: 22783437      PMCID: PMC3392585          DOI: 10.3892/ol.2012.653

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  12 in total

1.  Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis.

Authors:  H Sørbye; Y Bruserud; O Dahl
Journal:  Acta Oncol       Date:  2001       Impact factor: 4.089

2.  Sudden-onset thrombocytopenia with oxaliplatin.

Authors:  Frederick G Dold; Edith P Mitchell
Journal:  Ann Intern Med       Date:  2003-07-15       Impact factor: 25.391

Review 3.  Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.

Authors:  Marnelli A Bautista; W Tait Stevens; Chien-Shing Chen; Brian R Curtis; Richard H Aster; Chung-Tsen Hsueh
Journal:  J Hematol Oncol       Date:  2010-03-26       Impact factor: 17.388

4.  Oxaliplatin-induced immune pancytopenia.

Authors:  Behrouz Mansouri Taleghani; Oliver Meyer; Stefano Fontana; Norbert Ahrens; Urban Novak; Markus M Borner; Abdulgabar Salama
Journal:  Transfusion       Date:  2005-05       Impact factor: 3.157

Review 5.  Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis.

Authors:  A K Koutras; T Makatsoris; F Paliogianni; G Kopsida; A Onyenadum; C A Gogos; A Mouzaki; H P Kalofonos
Journal:  Oncology       Date:  2004       Impact factor: 2.935

6.  Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.

Authors:  Brian R Curtis; James Kaliszewski; Marisa B Marques; M Wasif Saif; Lisle Nabelle; Jules Blank; Janice G McFarland; Richard H Aster
Journal:  Am J Hematol       Date:  2006-03       Impact factor: 10.047

7.  Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

Authors:  J A Laurie; C G Moertel; T R Fleming; H S Wieand; J E Leigh; J Rubin; G W McCormack; J B Gerstner; J E Krook; J Malliard
Journal:  J Clin Oncol       Date:  1989-10       Impact factor: 44.544

8.  Fatal thrombocytopenia after oxaliplatin-based chemotherapy.

Authors:  Yu-Yun Shao; Ruey-Long Hong
Journal:  Anticancer Res       Date:  2008 Sep-Oct       Impact factor: 2.480

9.  Acute immune-mediated thrombocytopenia due to oxaliplatin administration: a case report.

Authors:  Filippo Pietrantonio; Maria Di Bartolomeo; Roberto Buzzoni; Emilio Bajetta
Journal:  Tumori       Date:  2010 Jan-Feb

10.  Oxaliplatin-induced Evan's syndrome.

Authors:  C C Earle; W Y Chen; D P Ryan; R J Mayer
Journal:  Br J Cancer       Date:  2001-02-02       Impact factor: 7.640

View more
  3 in total

1.  Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report.

Authors:  Hyun Sun Woo; Kyoung Hwa Lee; Phill Hoon Yoon; Su Ji Kim; Inkeun Park; Young Saing Kim; Hee Kyung Ahn; Junshik Hong; Dong Bok Shin; Sun Jin Sym
Journal:  Cancer Res Treat       Date:  2014-10-28       Impact factor: 4.679

2.  Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia.

Authors:  Elizabeth Pan; Eric Hsieh; Caroline Piatek
Journal:  Case Rep Oncol       Date:  2018-12-20

3.  Acute Immune-Mediated Thrombocytopenia due to Oxaliplatin and Irinotecan Therapy.

Authors:  Eric L Tam; Padma L Draksharam; Jennifer A Park; Gurinder S Sidhu
Journal:  Case Rep Oncol Med       Date:  2019-11-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.